ReviewCancer cell international2026

FcγR-driven chimeric receptor T cells in cancer therapy: a novel frontier in antibody-guided immunotherapy.

Hany E Marei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.